168 related articles for article (PubMed ID: 16939930)
1. [Relation of nerve growth factor expression with perineural invasion and pain in pancreatic cancer].
Hua ZM; Li Z; Lou DL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1251-3. PubMed ID: 16939930
[TBL] [Abstract][Full Text] [Related]
2. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
Ma J; Jiang Y; Jiang Y; Sun Y; Zhao X
J Gastroenterol Hepatol; 2008 Dec; 23(12):1852-9. PubMed ID: 19120874
[TBL] [Abstract][Full Text] [Related]
3. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer.
Koide N; Yamada T; Shibata R; Mori T; Fukuma M; Yamazaki K; Aiura K; Shimazu M; Hirohashi S; Nimura Y; Sakamoto M
Clin Cancer Res; 2006 Apr; 12(8):2419-26. PubMed ID: 16638847
[TBL] [Abstract][Full Text] [Related]
4. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer.
Zhu Z; Friess H; diMola FF; Zimmermann A; Graber HU; Korc M; Büchler MW
J Clin Oncol; 1999 Aug; 17(8):2419-28. PubMed ID: 10561305
[TBL] [Abstract][Full Text] [Related]
6. Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma.
Ben QW; Wang JC; Liu J; Zhu Y; Yuan F; Yao WY; Yuan YZ
Ann Surg Oncol; 2010 Aug; 17(8):2213-21. PubMed ID: 20162456
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
[TBL] [Abstract][Full Text] [Related]
8. Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer.
Dang C; Zhang Y; Ma Q; Shimahara Y
J Gastroenterol Hepatol; 2006 May; 21(5):850-8. PubMed ID: 16704535
[TBL] [Abstract][Full Text] [Related]
9. [Artemin and GFRalpha3 expressions and their relevance to perineural invasiveness and metastasis of pancreatic carcinoma].
Zhu DL; Luo DL; Luo G; Wang B; Gao JM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):428-32. PubMed ID: 19304517
[TBL] [Abstract][Full Text] [Related]
10. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor and tyrosine kinase A in human salivary adenoid cystic carcinoma: expression patterns and effects on in vitro invasive behavior.
Wang L; Sun M; Jiang Y; Yang L; Lei D; Lu C; Zhao Y; Zhang P; Yang Y; Li J
J Oral Maxillofac Surg; 2006 Apr; 64(4):636-41. PubMed ID: 16546643
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor and tyrosine kinase A receptor in oral squamous cell carcinoma: is there an association with perineural invasion?
Kolokythas A; Cox DP; Dekker N; Schmidt BL
J Oral Maxillofac Surg; 2010 Jun; 68(6):1290-5. PubMed ID: 20363547
[TBL] [Abstract][Full Text] [Related]
13. Patterns of expression and function of the p75(NGFR) protein in pancreatic cancer cells and tumours.
Wang W; Zhao H; Zhang S; Kang E; Chen Y; Ni C; Zhang S; Zhu M
Eur J Surg Oncol; 2009 Aug; 35(8):826-32. PubMed ID: 19041213
[TBL] [Abstract][Full Text] [Related]
14. Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?
Bergmann F; Ceyhan GO; Rieker RJ; Esposito I; Fischer L; Herpel E; Friess H; Schirmacher P; Kern MA
Hum Pathol; 2009 Jan; 40(1):50-7. PubMed ID: 18789481
[TBL] [Abstract][Full Text] [Related]
15. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
16. Heparanase expression in primary and metastatic pancreatic cancer.
Koliopanos A; Friess H; Kleeff J; Shi X; Liao Q; Pecker I; Vlodavsky I; Zimmermann A; Büchler MW
Cancer Res; 2001 Jun; 61(12):4655-9. PubMed ID: 11406531
[TBL] [Abstract][Full Text] [Related]
17. [The expression and significance of nerve growth factor and its receptors in pancreatic ductal adenocarcinoma].
Meng LX; Ding ZJ; Chen XP; Fei LS; Chi YH; Zhao ZG; Wang XF; Hao XS
Zhonghua Nei Ke Za Zhi; 2009 Jul; 48(7):562-5. PubMed ID: 19957796
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor and artemin are paracrine mediators of pancreatic neuropathy in pancreatic adenocarcinoma.
Ceyhan GO; Schäfer KH; Kerscher AG; Rauch U; Demir IE; Kadihasanoglu M; Böhm C; Müller MW; Büchler MW; Giese NA; Erkan M; Friess H
Ann Surg; 2010 May; 251(5):923-31. PubMed ID: 20395845
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.
Tobita K; Kijima H; Dowaki S; Kashiwagi H; Ohtani Y; Oida Y; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2003 Mar; 11(3):305-9. PubMed ID: 12579331
[TBL] [Abstract][Full Text] [Related]
20. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
